1. Home
  2. GOLF vs DFTX Comparison

GOLF vs DFTX Comparison

Compare GOLF & DFTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acushnet Holdings Corp.

GOLF

Acushnet Holdings Corp.

HOLD

Current Price

$89.59

Market Cap

6.1B

ML Signal

HOLD

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

N/A

Current Price

$42.31

Market Cap

5.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
GOLF
DFTX
Founded
1910
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.9B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
GOLF
DFTX
Price
$89.59
$42.31
Analyst Decision
Hold
Strong Buy
Analyst Count
7
8
Target Price
$83.67
$38.50
AVG Volume (30 Days)
336.6K
2.1M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
1.07%
N/A
EPS Growth
N/A
N/A
EPS
3.44
N/A
Revenue
$1,633,721,000.00
N/A
Revenue This Year
$5.76
N/A
Revenue Next Year
$2.44
N/A
P/E Ratio
$26.17
N/A
Revenue Growth
4.71
N/A
52 Week Low
$73.09
$14.62
52 Week High
$119.65
$49.70

Technical Indicators

Market Signals
Indicator
GOLF
DFTX
Relative Strength Index (RSI) 26.25 49.67
Support Level $86.26 $40.29
Resistance Level $92.18 $49.13
Average True Range (ATR) 4.54 2.71
MACD -1.42 -0.50
Stochastic Oscillator 3.93 22.69

Price Performance

Historical Comparison
GOLF
DFTX

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Share on Social Networks: